retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Dual and Triple Gut Peptide

While GLP-1...

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Find out everything about this - if its true and worth all the hype.

The science behind 24% weight loss results explained.

GLP-1 Drugs GLP-1 Drugs GLP-1 Drugs Distribution GLP-1 Drugs Distribution Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering

The problem is what the studies actually show.